1539 (1539) Fair Value & Analysis

Industrials · Market cap HK$1.3B

1 1539 1539 · HK

PriceHK$0.3650

Fair ValueHK$0.1100

Upside-69.9%

Quality43/100

Watch 1539 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$0.0800 – HK$0.1500

Fair value as of: Jul 2, 2026

From 17 valuation models · updated today

Share price +5.8% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2470 – HK$0.4150 · fair‑value band HK$0.0800 – HK$0.1500 · the HK$0.3650 price screens above the HK$0.1100 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1539 (1539) currently trades at HK$0.3650, while our model-based Fair Value estimate is HK$0.1100 — implying the stock looks roughly 69.9% overvalued today. We read business quality at 43/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 1539 generated revenue of HK$143M at a net margin of 29.8%. Revenue declined 18.4% year over year. It earns a return on equity of 14.3%. Net debt stands at HK$81.4M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$143M

Revenue growth (YoY) -18.4%

Net margin 29.8%

Return on equity 14.3%

Free cash flow −HK$67.8M FY2025

P/E ratio 36.5

More key figures

Operating margin 10.5%

EPS (TTM) HK$0.0100

EPS growth (YoY) +34.4%

Net debt HK$81.4M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1539 reported revenue of HK$157M in FY2025 versus HK$53.8M in FY2021, a compound +30.8%/yr. Reported net income was HK$35.5M in FY2025.

Revenue +30.8%/yr

FY21 HK$53.8M

FY22 HK$80.4M

FY23 HK$46.6M

FY24 HK$92.6M

FY25 HK$157M

Net income

FY21 −HK$280M

FY22 −HK$382M

FY23 −HK$25.1M

FY24 HK$8.4M

FY25 HK$35.5M

Is 1539 fairly valued? → Check now

Similar stocks

6 more Electrical Equipment & Parts stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Contemporary Amperex Technology Co CYATY	$22.68	$11.92	-47%
3750 3750	HK$681.00	HK$378.25	-44%
ABB Ltd ABLZF	$107.67	$35.93	-67%
DELTA DELTA	352.00 THB	39.71 THB	-89%
Vertiv Holdings VRT	$300.51	$96.06	-68%
Mitsubishi Electric Corporation MIELY	$81.81	$26.28	-68%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1539 (1539) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1100 versus a price of HK$0.3650 — about −70% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1539?

Our model-based fair value for 1539 is HK$0.1100 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.3650.

What is the quality score of 1539?

1539 has a Quality Score of 43/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1539 (1539)?

1539 reported trailing-twelve-month revenue of about HK$143M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1539?

The net profit margin of 1539 is about 29.8%, meaning it keeps roughly 29.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.